Culturally Relevant Exercise for Diabetes (CURE-D) (CURE-D)
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
California
-
Palo Alto, California, United States, 94301
- Palo Alto Medical Foundation Research Institute
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Sex: Females
- Ethnicity: South Asian
- Hemoglobin A1c ≥ 6.0 mg/dL
- A PAMF patient for ≥ 24 months
- Able and willing to enroll and meet the requirements of the study.
Exclusion Criteria:
- BMI > 35
- Insulin dependent
- Current atrial fibrillation
- Active treatment for cancer
- Diagnosis of a terminal illness and/or in hospice care
- Any serious medical condition which would prevent long-term participation or which would contraindicate physical activity
- Pregnant, lactating, or planning to become pregnant during the study period
- Inability to speak, read, or understand English
- No longer a PAMF patient or planning to transfer care outside of PAMF during the study period
- Investigator discretion for clinical safety or protocol adherence reasons.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: PREVENTION
- Allocation: RANDOMIZED
- Interventional Model: SINGLE_GROUP
- Masking: NONE
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
NO_INTERVENTION: Usual Care
|
|
|
EXPERIMENTAL: Bollywood Dance Exercise
Participants in the Bollywood Dance Exercise group will take part in an 8-week dance intervention.
The dance classes will take place 2 times per week, approximately 60 minutes per class, for 8 weeks total.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Hemoglobin A1c
Time Frame: Baseline
|
Baseline
|
|
|
Hemoglobin A1c
Time Frame: 8-week follow-up
|
Change from Baseline in Hemoglobin A1c level at 8 weeks
|
8-week follow-up
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Body Mass Index
Time Frame: Baseline, 8-week follow-up
|
Baseline, 8-week follow-up
|
|
|
Blood Pressure
Time Frame: Baseline, 8-week follow-up
|
Baseline, 8-week follow-up
|
|
|
Physical Activity
Time Frame: Baseline, 8-week follow-up
|
Assessed by accelerometers
|
Baseline, 8-week follow-up
|
Collaborators and Investigators
Sponsor
Sponsor
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Study Start
Primary Completion (ACTUAL)
Primary Completion
Study Completion (ACTUAL)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
First Posted
Study Record Updates
Last Update Posted (ESTIMATE)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- 13-07-250
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.